A transplant option that allows you to receive a kidney from a living donor who has an incompatible blood type; specialized medical treatment is required before and after transplant to prevent rejection.
ARPKD EL-PFDD 2023
What to Expect from the ARPKD EL-PFDD Meeting On August 29, 2023 the PKD Foundation will hold its first ever Externally Led Patient-focused Drug Development (EL-PFDD) Meeting on Autosomal Recessive PKD (ARPKD) and Congenital Hepatic Fibrosis (CHF). Should you attend the meeting? What should you...